Zydus launches oral anti-diabetic tablet Tenglyn
Healthcare major Zydus Cadila on Friday announced the launch of oral anti-diabetic tablet, Tenglyn Teneligliptin 20 mg tablets, which belongs to a new class of oral anti-diabetic agents, Gliptin... Zydus gets FDA nod for clinical trials of Sarolitazar
Zydus Cadila has received US health regulators nod to initiate phase II clinical trials of Sarolitazar, its new drug for treating high fat levels in body due to diabetes, obesity, and sedentary h... Financial Results with Results Press Release & Limited Review Report for Sept 30, 2015
Zydus Wellness Ltd has informed BSE about the Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended September 30, 2015. Board Intimation for Results & Closure of Trading Window
Zydus Wellness Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on October 21, 2015, inter alia, to consider & approve the unaudited financial results (limited reviewed) for the quarter / half year ended on September 30, 2015.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will... Shareholding Pattern For September 30, 2015
Zydus Wellness Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015. Updates on Outcome of AGM
Zydus Wellness Ltd has submitted to BSE a copy of Proceedings of the 21st Annual General Meeting (AGM) of the Company held on July 29, 2015. Disclosure of Voting results of AGM (Clause 35A)
Zydus Wellness Ltd has informed BSE regarding the details of Voting results at the 21st Annual General Meeting (AGM) of the Company held on July 29, 2015, under Clause 35A. Consolidated Results of E-Voting and Poll conducted at A G M
Zydus Wellness Ltd has submitted to BSE a copy of the consolidated Results of E-Voting and Poll conducted at the 21st Annual General Meeting of the Company. Zydus Wellness Q1 consolidated net profit up 14%
City-based healthcare player, Zydus Wellness Ltd on Wednesday posted consolidated net profit of Rs 19.5 crore for the first quarter ended June 30, 2015 as against Rs 17 crore in the same period la... Results Press Release
Zydus Wellness Ltd has submitted to BSE a copy of Results Press Release for the period ended June 30, 2015.